- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Programmed Cell Death-Ligand 2 (PD-L2, PDL2)
Total 94520 results
-
Merck Sharp & Dohme LLCAstellas Pharma Inc; Seagen Inc.Active, not recruitingBladder CancerHungary, United States, China, Argentina, Australia, Bulgaria, Canada, Colombia, Croatia, Czechia, France, Germany, Greece, Israel, Italy, Japan, Korea, Republic of, Malaysia, Philippines, Poland, Portugal, Romania, Russian Federation, Singapo... and more
-
Cairo UniversityAbdelhamid, Bassant Mohamed, M.D.; Mohamed, Ahmed A., M.D.; Hala Mostafa Gomaa; Mohamed saeid AliCompletedUltrasound Guided L1,L2 Paravertebral BlockEgypt
-
Peking University Cancer Hospital & InstituteRecruitingColorectal Cancer | Lung CancerChina
-
Merck Sharp & Dohme LLCActive, not recruitingBreast NeoplasmsKorea, Republic of, Germany, United States, United Kingdom, Argentina, Australia, Austria, Brazil, Canada, Chile, China, Colombia, France, Greece, Guatemala, Hungary, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, Phili... and more
-
Kyowa Kirin Co., Ltd.Kyowa Hakko Kirin Pharma, Inc.CompletedIdiopathic Parkinson's DiseaseUnited States, Canada, Czechia, Germany, Israel, Italy, Poland, Serbia
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingGlioblastoma | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Advanced Solid Tumors | Triple Negative Breast Cancer | Biliary Tract CancersUnited States, Argentina, Australia, Canada, Chile, Colombia, France, Germany, Israel, Italy, Korea, Republic of, Russian Federation, Spain, Switzerland, Taiwan, Thailand, United Kingdom
-
Makassed General HospitalRecruitingReduce Pain After HerniorrhaphyLebanon
-
Diwakar DavarImmunocore LtdNot yet recruitingUveal MelanomaUnited States
-
The University of Hong KongCompletedType 2 Diabetes | KetonemiaHong Kong
-
China Meitan General HospitalMarino Biotechnology Co., Ltd.UnknownRecurrent PD-L1+ Malignant Tumors | Metastatic PD-L1+ Malignant TumorsChina
-
Curis, Inc.CompletedAdvanced Solid Tumors or LymphomasUnited States, Spain, Korea, Republic of, United Kingdom
-
National Cancer Institute (NCI)Active, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Advanced Lymphoma | Advanced Malignant Solid Neoplasm | Refractory Lymphoma | Refractory Malignant Solid NeoplasmUnited States
-
Charitable Union for the Research and Education...Active, not recruitingVasectomy ReversalUnited States
-
Baylor Research InstituteCompleted
-
University Hospital, MontpellierFondation Jérôme Lejeune; association autour des Williams; réseau de santé Maladies...UnknownAnxiety | Williams SyndromeFrance
-
23andMe, Inc.Michael J. Fox Foundation for Parkinson's Research; The Parkinson's InstituteCompleted
-
University of Cape TownCompletedEpilepsy | Children | Sedation | ElectroencephalogramSouth Africa
-
Shanghai International Medical CenterUnknownAdvanced Solid Tumor | PD-1 Antibody | CAR-T CellsChina
-
Second Affiliated Hospital of Soochow UniversityNot yet recruiting
-
LEO PharmaCompletedPlaque Psoriasis | Psoriasis VulgarisGermany
-
AryoGen Pharmed Co.CompletedBioequivalence | Phase 1Iran, Islamic Republic of
-
CinnagenCompletedBioequivalence | Phase 1Iran, Islamic Republic of
-
Charite University, Berlin, GermanyCompletedActive Digital UlcersGermany
-
University Hospital, MontpellierCompletedPatients Recieving Anti-PD-1 or Anti-PD-L1 ImmunotherapiesFrance
-
Well Living Lab, Inc.Mayo ClinicRecruitingPhysical Activity | Sleep | Cognitive Function | Social IsolationUnited States
-
RenJi HospitalRecruitingUpper Urinary Tract Urothelial Carcinoma | Kidney Preservation | HER-2 ADC | PD-1antibodyChina
-
Samsung Medical CenterUnknown
-
Wuxi People's HospitalRecruitingCancer | PD-L1 Gene MutationChina
-
Merck Sharp & Dohme LLCRecruitingAdvanced Solid Tumors | Metastatic Solid TumorsCanada, Switzerland, United States
-
Giovanni MirabellaCompleted
-
Genzyme, a Sanofi CompanyDiacrin/Genzyme Corporation LLCCompleted
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Childhood Ependymoma | Advanced Malignant Solid Neoplasm | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Germ Cell Tumor | Recurrent Malignant Glioma | Recurrent Medulloblastoma | Recurrent Neuroblastoma | Recurrent Non-Hodgkin... and other conditionsUnited States, Puerto Rico
-
Chiron CorporationUnknownHIV InfectionsUnited States
-
Ningbo Cancer HospitalUnknownAdvanced Malignancies | PD-1 Antibody | CAR-T CellsChina
-
DePuy SpineCompletedDegenerative Disc DiseaseUnited States
-
Jiangsu vcare pharmaceutical technology co., LTDCompletedHealthy Subjects | PK/PDChina
-
Luzerner KantonsspitalNot yet recruitingPain, Postoperative | IVFSwitzerland
-
Radboud University Medical CenterZonMw: The Netherlands Organisation for Health Research and Development; Dutch...CompletedHematological MalignanciesNetherlands
-
University of PittsburghCompletedTotal Hip ArthroplastyUnited States
-
Regeneron PharmaceuticalsTerminatedAdvanced PD-L1 Positive MalignanciesUnited States
-
Instituto Nacional de Cancer, BrazilCompletedTriple Negative Breast Cancer | Triple Negative Breast NeoplasmsBrazil
-
Istituto Oncologico Veneto IRCCSJanssen Diagnostics, LLCUnknownMetastatic MelanomaItaly
-
Guohui LiRecruitingPD-1 | Immune Related Adverse EventsChina
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
University Medical Center GroningenActive, not recruitingLocally Advanced or Metastatic Solid Tumors Irrespective of PD-L1 ExpressionNetherlands
-
Hoffmann-La RocheCompletedLymphocytic Leukemia, ChronicGermany
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Mantle Cell LymphomaUnited States
-
Inge Marie SvaneCompletedPolycythemia Vera | Essential ThrombocythemiaDenmark
-
The Second Affiliated Hospital of Harbin Medical...UnknownContract Management PD
-
Gruppo Italiano Malattie EMatologiche dell'AdultoCompletedPatients With CLL Relapsing After an Initial Response (CR, PR ≥ 6 Months) Following no More Than Two Prior Treatment Lines; or | Patients With CLL Refractory (SD, PD or CR/PR < 6 Months) Following no More Than Two Prior Treatment LinesItaly